Parallel-Advisors

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-08
Total Holdings
3,520
Total Value
4434574142
Accession Number
0001690010-25-000004
Form Type
13F-HR
Manager Name
Parallel-Advisors
Data Enrichment
80% identified
2,826 identified694 unidentified

Holdings

3,520 positions • $4.4B total value
Manager:
Search and click to pin securities to the top
Page 169 of 176
Spyre Therapeutics, Inc.
Shares:14
Value:$226
% of Portfolio:0.0% ($226/$4.4B)
Torrid Holdings Inc.
Shares:41
Value:$225
% of Portfolio:0.0% ($225/$4.4B)
FIRST ADVANTAGE CORP
Shares:16
Value:$225
% of Portfolio:0.0% ($225/$4.4B)
Limbach Holdings, Inc.
Shares:3
Value:$223
% of Portfolio:0.0% ($223/$4.4B)
Origin Materials, Inc.
Shares:334
Value:$222
% of Portfolio:0.0% ($222/$4.4B)
Brookfield Renewable Partners L.P.
Shares:10
Value:$222
% of Portfolio:0.0% ($222/$4.4B)
Prime Medicine, Inc.
Shares:110
Value:$219
% of Portfolio:0.0% ($219/$4.4B)
Arcutis Biotherapeutics, Inc.
Shares:14
Value:$219
% of Portfolio:0.0% ($219/$4.4B)
Adverum Biotechnologies, Inc.
Shares:50
Value:$219
% of Portfolio:0.0% ($219/$4.4B)
Global Business Travel Group, Inc.
Shares:30
Value:$218
% of Portfolio:0.0% ($218/$4.4B)
Sila Realty Trust, Inc.
Shares:8
Value:$214
% of Portfolio:0.0% ($214/$4.4B)
MediaAlpha, Inc.
Shares:23
Value:$213
% of Portfolio:0.0% ($213/$4.4B)
HOVNANIAN ENTERPRISES INC
Shares:2
Value:$209
% of Portfolio:0.0% ($209/$4.4B)
Evolv Technologies Holdings, Inc.
Shares:66
Value:$206
% of Portfolio:0.0% ($206/$4.4B)
Oruka Therapeutics, Inc.
Shares:20
Value:$205
% of Portfolio:0.0% ($205/$4.4B)
LANDS' END, INC.
Shares:20
Value:$204
% of Portfolio:0.0% ($204/$4.4B)
FORWARD AIR CORP
Shares:10
Value:$201
% of Portfolio:0.0% ($201/$4.4B)
Altimmune, Inc.
Shares:40
Value:$200
% of Portfolio:0.0% ($200/$4.4B)
Disc Medicine, Inc.
Shares:4
Value:$199
% of Portfolio:0.0% ($199/$4.4B)
Aeva Technologies, Inc.
Shares:2.5K
Value:$198
% of Portfolio:0.0% ($198/$4.4B)